Digitalising healthcare for aging-in-place

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

PCL Health is expanding its digital footprint with wearables designed to increase and improve remote health monitoring for aging-in-place solutions.

DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the company featured in this article to support its current funding round. Qualifying investors can find out more via the Longevity.Technology Investment Portal.

PCL Health has created a remote monitoring and analytics platform which drives health and wellbeing for elders using new technologies. An AI-driven health score is combined with wearable technology and an app, to help patients, carers and families monitor their own health. The company has successfully completed two pilots in India that demonstrated the utility of its platform and is engaged with the NHS in the UK; however, not one to rest on its laurels, the company is actively improving its interface and expanding its wearables tech.

Longevity.Technology: When it comes to apps for aging-in-place, companies need to be mindful not to prioritise style over substance. Sure, a smart clean interface is aesthetically pleasing, but is it intuitive to use, especially for those in the population who are digital immigrants, rather than natives?

PCL is responding to the demands of the market; listening to feedback, engaging with customers and responding to the needs of the customer base – a refined, improved product should be better for outcomes and balance sheets.

PCL is on a mission to help people lead longer, more independent and healthier lives. Acknowledging the burden on the increasingly-squeezed sandwich generation (those aged between 40 and 60), the company wants to empower people to monitor their loved-ones’ healthcare quickly, efficiently, intelligently and securely.

PCL’s range of technology is designed to bring about medical-grade healthcare monitoring to the comfort of home, and its innovative, predictive algorithm aims to discover unknown health conditions and pick up problems before they become severe.

Obviously, the COVID-19 pandemic has thrown a spotlight on remote healthcare options, but PCL has longer-term solutions in its sights; with the Silver Tsunami fast approaching, and predictions that the aging population will outnumber the under-18s by 2035 in the US, the demand for technology that will foster independent living will only increase – and it’s a demand that PCL wants to meet.

Ovarian Longevity webinar

PCL Health

We reached out to Tornike Asatiani, PCL’s Chief Operating Officer to find out more about the expansion of their technology and what it could mean for the aging-in-place marketplace.

“After talking to various customers, we realised that even though we created a wonderful solution for those looking for a remote health monitoring solution for their elderly relatives, the solution itself was not that great for the elderly people themselves,” Asatiani told Longevity.Technology, referring to the wearable in PCL’s system, he said:

“In order to motivate our senior citizens to actively use the watch to share vital health measurements, we needed to add an attractive, easy-to-use solution for them as well. That’s how we came up with an idea of creating a separate Tablet App with large buttons that’s limited to essential functionality. Features that the elderly really need: Tap-to-Call, Notifications and Reminders, Photo/Video sharing and easy Vital Measurement collection. This completes our Connected Care platform and lowers the barriers for new customer acquisition. Everyone loves the new app.”

Although an aging population may be digital immigrants, many of them are tech-savvy, meaning competition can be fierce and companies need to listen to their customers, or risk losing them to the competition. And the market shows that wearables are a popular way of tracking health and wellbeing.

“We decided to integrate the wearable technology because of the feedback on our earlier used multi-sensor tool,” explained Asatiani. “Elderly patients found it difficult to use the multi-sensor tool on their own so we had to come up with something that they can wear and easily interact with. We already received amazing feedback from potential customers and are soon starting a paid trial with a large Domiciliary Care Software organisation.

“Our smart watch is not the only wearable though. As a device-agnostic platform, we are planning to integrate with iWatch, Galaxy Watch, Fitbit and any other mainstream devices to allow our users to sync their health data from any available device. We always look for opportunities to enhance our ecosystem and bring high-end devices to our platform as part of our technology-driven mindset.”

 


 

Ovarian Longevity webinar

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. First Longevity is targeted exclusively at sophisticated investors who understand these risks and make their own investment decisions. Investment opportunities have not been approved as financial promotions and are not covered by the Financial Services Compensation Scheme (FSCS) and you may not have access to the Financial Ombudsman Service (FOS). If you are in any doubt about the action you should take or the contents of any of the Financial Promotion received, you should contact your stockbroker, solicitor, accountant, bank manager or other professional adviser authorised under the Financial Services and Markets Act 2000, who specialises in advising on bonds, shares and other securities, including unlisted securities. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.  Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status.

Images courtesy of PCL Health
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Predicting possible Alzheimer’s with nearly 100% accuracy

Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer's disease from brain images with an accuracy of over 99%. Researchers...

Longevity industry “taking shape”

ARDD 2021 kicks off: sessions to cover longevity topics from AI and senolytics to mitochondria and stem cell rejuvenation. Following yesterday’s workshops, ARDD 2021 really...

The need to educate in longevity

Lots to learn about longevity at ARDD 2021: from pharma and startups to physicians and high schoolers. This week, we’ll be bringing you a wealth...
Nutriop